suMMAy The clinical importance of an undetectable thyroid stimulating hormone (TSH) concentration ( < 0.2 mU/1) was studied in a consecutive series of 2573 requests for routine thyroid function tests. Two hundred and seventeen (8-4%) patients had an undetectable TSH concentration, and of these 39 (18%) had otherwise normal thyroid hormone concentrations and no history of thyroid disease. In a follow up study 71 patients (34 outpatients and 37 inpatients) with undetectable TSH concentration associated with otherwise normal thyroid hormone concentrations were randomly selected during routine reporting of thyroid function test results. None of these patients had a history of thyroid disease. Sex hormone binding globulin concentrations were increased in five out of50 of these patients and antithyroid antibodies were detectable in four out of49, suggesting that in most cases the isolated undetectable TSH concentration was not associated with thyroid dysfunction, particularly hyperthyroidism. Isolated undetectable TSH concentration was observed in both inpatients and outpatients and was not associated with any particular clinical condition. Repeat specimens were received in 54 ofthe 71 patients and TSH concentration remained persistently undetectable in 35 of these.
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Sensitive immunometric methods have been developed for measuring the concentration of serum thyroid stimulating hormone (TSH).'2 Many studies using such assays have shown that TSH is suppressed in hyperthyroidism and concentrations are clearly different from those in euthyroid subjects.-5 On the basis of such studies it has been suggested that TSH by sensitive assay is suitable as a first line test of thyroid function.6 There have been some studies, however, in which undetectable TSH concentrations have been found in patients who did not have hyperthyroidism.79.
During an analysis of a series ofconsecutive thyroid function tests sent to this laboratory several patients were observed with undetectable TSH concentrations associated with thyroxine (T4) and tri-iodothyronine (T3) concentrations within the reference range. It was decided to identify a group of such patients during routine reporting of results and to request follow up specimens and detailed clinical information.
Sex hormone binding globulin (SHBG) concentration was measured in these patients in an attempt to clarify thyroid state as the concentration of this protein is increased in thyrotoxicosis.'°" AntiAccepted for publication 28 July 1989 -microsomal and antithyroglobulin antibodies were also measured.
Material and methods TSH was measured routinely by an in-house immunoradiometric assay (IRMA) using two monoclonal antibodies to TSH. Intrabatch coefficient of variation (CV) was < 10% at 04-59 mU/l with a detection limit of 0 12 mU/l calculated using patient samples with low TSH concentrations, as described by Fraser and Wilde.'2 Interbatch CV was < 10% in the concentration range 0-83-16 mU/l. The reference range was 0-5-5 5 mU/l in euthyroid subjects (n = 94).
TSH was also measured by the RIAgnost immunoradiometric assay TSH kit in specimens from several patients; the detection limit was 0 03 mU/l as calculated by the method of Fraser and Wilde.'2 The lower limit of the reference range was 0-3 mU/I (n = 94) as determined in the DHSS sponsored evaluation of high sensitivity TSH assay kits.'3 The RIAgnost kit was chosen as it showed the best performance in the DHSS sponsored evaluation. '3 Serum T4 and T3 concentrations were measured by in-house radioimmunoassays and free T4 by the Amerlex M radioimmunoassay kit (reference ranges:
T4 50-150 nmol/l; T3 1-02-9 nmol/l; free T4 9-26 pmol/ 1). The data thus suggest that the finding of an isolated undetectable TSH concentration was not generally associated with hyperthyroidism in this group of both inpatients and outpatients.
Serum TSH concentration had returned to normal in a number of both outpatients and inpatients by the time that a second specimen was taken, although it remained persistently undetectable in other patients. In all patients thyroid hormone concentrations remained within the reference range. A large percentage of patients in the study was elderly but this may simply reflect the pattern of specimens sent to the laboratory. The current view is also that serum TSH concentration does not change with age in the absence of thyroid disease.'4 Isolated undetectable TSH was not associated with any particular clinical condition.
To establish if the findings of the study were due to limitations in the sensitivity of the in-house TSH IRMA, specimens were also measured in the RIAgnost TSH kit which has a lower detection limit. Using this assay known hyperthyroid patients consistently had undetectable TSH concentrations.'3 In this study 75% of the initial specimens had measurable TSH concentrations in the RIAgnost assay, although the concentrations were still below the lower limit of the reference range for the kit. The use of a more sensitive method for TSH may therefore decrease the number of patients who are classified as having an undetectable TSH concentration suggestive of thyrotoxicosis. Care would still be required in interpreting measurable TSH concentrations below the lower limit of the reference 1239 range. This finding is different from that of Spencer et al,9 who concluded that their finding of patients with undetectable TSH concentrations in an unselected hospital population was not related to method.
Several studies have now suggested that serum TSH may be suppressed in severe illness, particularly in patients receiving treatment with glucocorticoids and dopamine.8 5 '16 Spencer et al have shown that in a large series of unselected admissions to an acute medical unit an undetectable serum TSH was three times more likely to be due to non-thyroidal illness than hyperthyroidism.9
This study has shown that TSH may also be suppressed in patients who are attending hospital as outpatients but who may have several clinical problems. Undetectable serum TSH associated with T4, T3, and free T4 concentrations within the reference range is not therefore diagnostic ofhyperthyroidism in either inpatients or outpatients, a view supported by measurement of other indices of thyroid function, such as detection of antithyroid antibodies and SHBG concentration.
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